Come up with a name for your new list and we'll add to it:
GlakoLens raised a round of funding on May 24, 2017. Investors include
ACT Venture Partners.
GlakoLens develops a novel non-invasive continuous intra-ocular pressure (IOP) diagnostics and monitoring device based on proprietary technology licensed from Boğaziçi University. The company's stra…